Several actions taken by the current administration may affect the landscape of prevention of HIV, prompting an analysis of these effects.

Lamivudine/dolutegravir is effective as first-line therapy for HIV infection, with low rates of treatment failure.

The U.S. Department of State announced a life-saving development to bring U.S.-based Gilead Sciences' breakthrough drug lenacapavir to market in Uganda, one of just ten high-burden HIV countries where ...

Our projections show the substantial detrimental impacts that cuts to PEPFAR funding could have. Mitigation measures, including funding through alternative international donors or domestic government ...